EcoDrugPlus

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSPSNG00000005065
Gene Symbol: F2R
3 Cross references
327 Possible Orthologues:

Coagulation Factor Ii, Thrombin

Ensembl ID : ENSPSNG00000005610
Gene Symbol: F2
3 Cross references
85 Possible Orthologues:

Coagulation Factor Iii, Tissue Factor

Ensembl ID : ENSPSNG00000018418
Gene Symbol: F3
3 Cross references
243 Possible Orthologues:

Coagulation Factor Vii

Ensembl ID : ENSPSNG00000020088
Gene Symbol: F7
1 Cross references
274 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSPSNG00000020166
Gene Symbol: F10
1 Cross references
237 Possible Orthologues:

Coagulation Factor Xi

Ensembl ID : ENSPSNG00000021782
Gene Symbol: F11
1 Cross references
216 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSPSNG00000012111
Gene Symbol: CCDC6
3 Cross references
219 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSPSNG00000018376
Gene Symbol: CSF1R
3 Cross references
206 Possible Orthologues:

Complement C1s

Ensembl ID : ENSPSNG00000004705
Gene Symbol: C1S
3 Cross references
199 Possible Orthologues:

Complement C5

Ensembl ID : ENSPSNG00000019713
Gene Symbol: C5
3 Cross references
208 Possible Orthologues:

Complement Factor D

Ensembl ID : ENSPSNG00000007977
Gene Symbol: CFD
1 Cross references
133 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSPSNG00000021305
Gene Symbol: CRHR1
3 Cross references
240 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).